Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rethinking European Expansion: What Life Science Leaders Can Learn from Latvia, Upcoming Webinar Hosted by Xtalks Pharmaville
-
The 401(k) Wake-Up Call Helps Readers Avoid Costly Mistakes and Create Stronger Retirements
-
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
-
CoLab Launches 4.0 — Built for Human Decision-Makers in an AI-First World
-
Top YouTube Creator PrestonPlayz Selects ADM Endeavors (OTCQB: ADMQ) for Merchandise Production and Fulfillment at the Company's New 100,000-Square-Foot Facility
-
Otovo Closes $7.25 Million Financing Round to Accelerate Global Growth
-
FMS Solutions Announces 2nd Annual Profit Summit for Independent Grocery Operators
-
Picsart's Earn Program Crosses $1M in Creator Earnings Less Than 2 Months Since Launch
-
IAS’s 21st Media Quality Report Shows How Proactive Optimization Turns Media Quality into a Performance Engine
-
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome
-
Via to Announce Second Quarter 2026 Financial Results on August 6, 2026
-
Spinogenix Appoints Harvard Medical School Professor of Neurology Steven E. Arnold, MD, to Scientific Advisory Board
-
duPont REGISTRY Group Announces Confidential Filing of Draft Registration Statement for Proposed Initial Public Offering
-
Georgene Huang appointed Chief Product Officer of PEI Group
-
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
-
Hasbro Introduces Blooms by Play-Doh, A New Creative Experience Designed for Adults
-
Cheniere Announces Timing of Second Quarter 2026 Earnings Release and Conference Call
-
TOYO participates in Citi's "10-Hour Teach-In: The Space Economy & Future of AI" Investor Webcast
-
Pagaya Announces Timing of Second Quarter 2026 Earnings Release
-
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 44th Annual Meeting July 15 - 18
-
Micron Announces Up to $3 Billion Strategic Investment to Strengthen U.S. Semiconductor Ecosystem
-
Alliance Authentic at Comic-Con 2026: The Collecting Platform “For A New Generation” (Forbes) Arrives in San Diego July 23-26
-
Blue Gold Ltd Announces Initiatives to Regain Nasdaq Compliance and Strengthen its Financial Position
-
Heald Expands Access to AI-Powered Glucose Intelligence for Over-the-Counter CGM Users
-
AVAX One Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
-
The Counter-Drone Technology Gap That Is Leaving Agencies Blind to the Fastest-Growing Threat
-
Globaltech Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
-
Yorkville International Capital Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 13, 2026
-
OZOP Energy Solutions, Inc. Highlights Varon USA’s Joint Venture with Ballislife Through Latest NBA Athlete Partnership
-
The Vita Coco Company to Report Second Quarter 2026 Financial Results on July 23, 2026
-
American Fusion Inc. (OTC: AMFN) Developing Tech that Converts Energy into Portable Asset for Military, Commercial Sectors
-
Wrap Technologies Inc. (NASDAQ: WRAP) Position in Global Safety Space Strengthened with Recent ATF Ruling
-
Safe Harbor Introduces Its Operating Model for Cannabis Banking at ACB Cannabis Banking eXperience Conference
-
GMEX Robotics Appoints Brian Hartzband to Lead U.S. Operations, Accelerating North American Expansion
-
The Greenest Car Wash is the One You Don’t Do at Home
-
Learfield Partners with SponsorCX to Advance Sponsorship Operations, Elevate Brand Partnerships, and Drive Performance Across College Sports
-
TRNR Publishes New Investor Deck with 67% Increase of 2026 Pro Forma Revenue Guidance to More Than $50M
-
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis
-
Important Notice to Long-Term Shareholders of GRAIL, Inc. (NASDAQ: GRAL); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)); Photronics, Inc. (NASDAQ: PLAB); and Power
-
Our Bond Expands its University Market Internationally Through Partnership With Leading University
-
Man Group PLC : Form 8.3 - JTC Plc
-
cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation
-
Lifestyle Trends Shaping How People Define Success, Balance, and Wellbeing Today
-
Rocket One Adds SpaceXAI API to Its AI Technology Stack, Advancing Next-Generation Space and Defense Computing
-
Prudential Financial, Inc. to Announce Second Quarter 2026 Earnings; Schedules Earnings and Strategy Call
-
Anfield Energy Announces Lease of Additional Patented Mining Claims Expanding Land Holdings for JD-5 and Slick Rock Projects
-
Lion One Reports 3,291 oz in Quarterly Gold Recovery
-
Constructor Has the Most #1 Rankings in Gartner® Critical Capabilities for Search and Product Discovery Report
-
Greg Maffei and Danny Epstien to Launch the HRL (Horse Racing League)
